02199nas a2200229 4500000000100000008004100001100001600042700001300058700001200071700001400083700001800097700001300115700001700128700001200145700002000157245009000177856007100267300000900338490000700347520160100354022001401955 2019 d1 aPepineli AC1 aAlves HV1 aTiyo BT1 aMacedo LC1 aVisentainer L1 aNeto QAL1 aZacarias JMV1 aSell AM1 aVisentainer JEL00aVitamin D receptor gene polymorphisms are associated with leprosy in Southern Brazil. uhttps://www.frontiersin.org/articles/10.3389/fimmu.2019.02157/full a21570 v103 a

Vitamin D, together with its nuclear receptor (VDR), plays an important role in modulating the immune response, decreasing the inflammatory process. Some polymorphisms of the gene, such as I (G>A rs1544410)I (G>T rs7975232), and I (T>C rs731236) could affect its stability and mRNA transcription activity, while I T>C (rs2228570) gives a truncated protein with three fewer amino acids and more efficiency in binding vitamin D. This study evaluated these four polymorphisms in the immunopathogenesis of leprosy in 404 patients and 432 control individuals without chronic or infectious disease in southern Brazil. When analyzing differences in the allele and genotype frequency of polymorphisms between patients (leprosy , multibacillary, and paucibacillary clinical forms) and controls, we found no statistically significant association. Regarding haplotype analysis, the bAt haplotype was associated with protection from leprosy ( = 0.004, OR = 0.34, CI = 0.16-0.71) and from the multibacillary clinical form ( = 0.005, OR = 0.30, CI = 0.13-0.70). In individuals aged 40 or more years, this haplotype has also showed protection against leprosy and multibacillary (OR = 0.26, CI = 0.09-0.76; OR = 0.26, CI = 0.07-0.78, respectively), while the BAt haplotype was a risk factor for leprosy in the same age group (OR = 1.34, CI = 1.04-1.73). In conclusion, despite having found no associations between the gene polymorphisms with the development of leprosy, the haplotypes formed by the I, I, and I polymorphisms were associated with leprosy and the multibacillary clinical form.

 a1664-3224